Rivera-Rosas CN, Soriano-Zambrano AP, Vázquez-Castellanos JL, Trujillo-López S

Language: Spanish
References: 11
Page: 57-60
PDF size: 132.72 Kb.

ABSTRACT

Acinetobacter baumannii is a multidrug-resistant, gram-negative coccobacillus that commonly causes healthcare- associated infections; however, few cases of community-acquired pneumonia have been documented in Latin American countries. We report a fatal case in a 57-year-old man admitted to a hospital in Mexico with fever, respiratory failure, and imaging findings consistent with community-acquired pneumonia, in which multidrug-resistant.
A. baumannii was subsequently identified. Timely clinical suspicion and bronchial secretion culture could guide clinicians toward effective antibiotic therapy for these patients, potentially improving their prognosis.

REFERENCES

1. Antunes, L.C., Visca, P. y Towner, K.J., “Acinetobacterbaumannii: evolution of a global pathogen”, Pathog Dis, 2014, 71 (3): 292-301.

2. Dexter, C., Murray, G.L., Paulsen, I.T. y Peleg, A.Y., “Community-acquired Acinetobacter baumannii: clinical characteristics,epidemiology and pathogenesis”, ExpertRev Anti Infect Ther, 2015, 13 (5): 567-573.

3. Ibrahim, S., Al-Saryi, N., Al-Kadmy, I.M.S. y Aziz, S.N.,“Multidrug-resistant Acinetobacter baumannii as anemerging concern in hospitals”, Mol Biol Rep, 2021, 48(10): 6987-6998.

4. Ong, C.W., Lye, D.C., Khoo, K.L., Chua, G.S., Yeoh, S.F.,Leo, Y.S., Tambyah, P.A. y Chua, A.C., “Severe community-acquired Acinetobacter baumannii pneumonia: anemerging highly lethal infectious disease in the Asia-Pacific”,Respirology, 2009, 14 (8): 1200-1205.

5. Leung, W.S., Chu, C.M., Tsang, K.Y., Lo, F.H., Lo, K.F. yHo, P.L., “Fulminant community-acquired Acinetobacterbaumannii pneumonia as a distinct clinical syndrome”,Chest, 2006, 129 (1): 102-109.

6. Sosa Hernández, Ó., González Almaguer, C.G., ArriagaRivera, C.E. et al., “Neumonía adquirida en la comunidadpor Acinetobacter pittii, primer reporte en México”,Enf Infec Microbiol, 2021, 41 (4): 177-179.

7. Davis, J.S., McMillan, M., Swaminathan, A.,, Kelly, J.A.,Piera, K.E., Baird, R.W., Currie, B.J. y Anstey, N.M., “A16-year prospective study of community-onset bacteremicAcinetobacter pneumonia: low mortality withappropriate initial empirical antibiotic protocols”, Chest,2014, 146 (4): 1038-1045.

8. Riddles, T. y Judge, D., “Community-acquired, bacteraemicAcinetobacter baumannii pneumonia: a retrospectivereview of cases in tropical Queensland, Australia”,Trop Med Infect Dis, 2023, 8 (8): 419.

9. Serota, D.P., Sexton, M.E., Kraft, C.S. y Palacio, F., “Severecommunity-acquired pneumonia due to Acinetobacterbaumannii in North America: case report and reviewof the literature”, Open Forum Infect Dis, 2018, 5 (3):ofy044.

10. Brigo, I.R., Yamamoto, L.R. y Molina, R.J., “Community-acquired Acinetobacter baumannii pneumonia: arare case in Brazil”, Rev Soc Bras Med Trop, 2022, 55:e03012022.

11. Ho, P.L., Cheng, V.C. y Chu, C.M., “Antibiotic resistancein community-acquired pneumonia caused by Streptococcuspneumoniae, methicillin-resistant Staphylococcusaureus, and Acinetobacter baumannii”, Chest, 2009,136 (4): 1119-1127.